लोड हो रहा है...
Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer
BACKGROUND: Recent advances in targeted therapies have raised expectations that the clinical application of biomarkers would improve patient’s health outcomes and potentially save costs. However, the cost-effectiveness of biomarkers remains unclear irrespective of the cost-effectiveness of correspon...
में बचाया:
| में प्रकाशित: | PLoS One |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Public Library of Science
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6157891/ https://ncbi.nlm.nih.gov/pubmed/30256829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0204496 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|